Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-13-425248
Filing Date
2013-11-04
Accepted
2013-11-04 16:18:00
Documents
7
Period of Report
2013-11-04

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d622559d6k.htm 6-K 10595
2 EX-99.1 d622559dex991.htm EX-99.1 24918
3 GRAPHIC g622559g27u26.jpg GRAPHIC 110110
4 GRAPHIC g622559g31d40.jpg GRAPHIC 104565
5 GRAPHIC g622559g39p49.jpg GRAPHIC 94875
6 GRAPHIC g622559g45k97.jpg GRAPHIC 73177
7 GRAPHIC g622559g80z55.jpg GRAPHIC 86767
  Complete submission text file 0001193125-13-425248.txt   684076
Mailing Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 131189338
SIC: 2834 Pharmaceutical Preparations